EvoNK·EvoStem Diabetes complications immunity/regeneration
Why is managing diabetes complications important?
Limitations of existing treatments and differences between LACELLIC
Why EvoNK·EvoStem Hybrid is different
A composition designed to control inflammation and regenerate blood vessels and nerves.
The key to regenerating diabetes complications suggested by LACELLIC
LACELLIC Diabetes Complications Medical Tour
LACELLIC MEDICAL TOUR PACKAGE The most talked-about part of diabetes is not the blood sugar levels themselves, but the changes that follow.
It is known that continuous hyperglycemia and chronic inflammation lead to gradual damage to microscopic blood vessels and peripheral nerves throughout the body, such as neuropathy, retinopathy, nephropathy, and diabetic foot.
Cases of site-specific complications have been reported.
There are signs that are perceived first in everyday life, such as numbness in the fingertips and toes, the feeling that wounds are not healing as quickly as before, and subtle changes in vision.
However, an individual's condition cannot be judged based on these descriptions alone. Confirmation through glycated hemoglobin (HbA1c), kidney function test, fundus examination, and nerve conduction test through endocrinology specialist care should be given priority.
Approaches considered to date
To manage diabetes complications, blood sugar lowering drugs, insulin, blood pressure and lipid management, diet and exercise, and regular checkups for each area are standard.
This management plays an important role in slowing progression and reducing risk and is at the discretion of your health care provider.
On the one hand, it has been mentioned that these methods focus on controlling current levels, making it difficult to return already damaged nerve networks or narrowed microvascular vessels to their original function.
At this point, research is continuing on approaches that look at inflammation control and tissue regeneration together. An approach that views inflammation and regeneration together — EvoNK · EvoStem
LACELLIC's cell platform has split roles.
• EvoNK—NK immune cell therapy. Acts as a shield for the immune system that recognizes and eliminates abnormal cells • EvoStem—Stem cell regeneration treatment using autologous cells. The center of regeneration that creates an environment for tissues to repair themselves • EvoX—a nano-signaling substance.
Helps communicate between cells and helps transplanted cells settle down
The reason the two platforms are seen together in diabetes complications is because this disease has both the problem of inflammation continuing to damage blood vessels and the problem of tissue damage already.
Here's where the hybrid configuration comes together in managing diabetes complications:
• Peripheral nerve and microvascular regeneration
• Sustained control of chronic inflammatory signals • Goal of improving systemic microcirculation • Goal of delaying progression of complications
EvoStem is designed to minimize immune rejection by utilizing the patient's own autologous cells and platelet technology.
It is a program that goes one step further from managing the numbers and focuses on slowing down the rate at which damage accumulates and maintaining the scope of daily activities.
The program is planned as a combination of EvoNK and EvoStem administered a total of 24 times over 12 weeks.
These numbers are a component of the program and are not indicative of treatment results.
However, the application and method of diabetes complications vary depending on the duration of the disease, the state of blood sugar control, the site and extent of the complication that has already developed, kidney function, and cardiovascular status.
The criteria for review are different, especially in cases with reduced kidney function and in cases where there is a wound with infection.
Since the composition of a program and its applicability to a specific individual are two different issues, priority is given to the individual review process after sufficient testing and consultation with medical staff.
Also, please understand that this is not a concept of eliminating complications, but rather an approach aimed at slowing progression and maintaining remaining function.
It is a priority to continue the ongoing blood sugar, blood pressure, lipid management and regular check-ups according to the judgment of the medical staff in charge, and the cell program is not a replacement for this.
Do not stop taking the medication arbitrarily and be sure to consult your doctor.
Medical tour information for overseas patients For overseas patients, not only treatment and treatment, but also the schedule before and after visiting Korea must be considered.
LACELLIC provides consultation regarding treatment schedules and medical tourism so that overseas patients can more conveniently prepare their domestic treatment schedule.
Information on movement and stay after arrival at the airport, remote biomarker tracking and follow-up care after returning home, and connection with global partner networks in Southeast Asia, the Middle East, and the Americas are also provided.
The basic schedule is a one-time visit to Korea, from precise diagnosis to cell transplantation, and then repeated visit cycles and ongoing management based on the EvoX platform are reviewed.
The specific scope of support may vary depending on the patient's schedule and program and can be confirmed through prior consultation. Since your existing blood sugar management schedule and medication must be continued during your stay, we recommend that you share your current medications and insulin schedule before your visit.
The method of application of cell programs may vary depending on the individual's condition. LACELLIC also prioritizes the process of confirming applicability based on sufficient testing and consultation with medical staff.
The 24 sessions over 12 weeks in this text are the number of program sessions and do not guarantee individual treatment results. The scope of support for global partner network connections may vary depending on the partner organization and country, and may not be available in all regions.
Progress and results may vary depending on the individual's condition.
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul 71-9 Samseong-dong, Gangnam-gu, Seoul
Inquiry +82 10-7667-6057
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul
